Latest stories on EYPT
EyePoint Pharmaceuticals Settles DEXYCU Case, Enhances Compliance Oversight
TipRanks56 · neutralgeneral
EyePoint, Inc. (EYPT) files 8-K
SEC 8-K50 · neutralgeneral
EyePoint to pay $4.6M to settle with DoJ over kickback claims
Seeking Alpha34 · bearishgeneral
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | EYPT Stock News
StockTitan50 · neutralgeneral
EyePoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer
Business Insider55 · neutralgeneral
EyePoint Stockholders Approve Incentive Plan and Board Slate
TipRanks50 · neutralgeneral
EyePoint, Inc. (EYPT) files 8-K
SEC 8-K50 · neutralgeneral
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | EYPT Stock News
StockTitan50 · neutralgeneral
EyePoint, Inc. (EYPT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral
EyePoint Pharma Bets Big on DURAVYU Pivotal Data
TipRanks56 · neutralproduct/pr
EyePoint: DURAVYU's Durability Could Drive Significant Upside
Seeking Alpha67 · bullishproduct/pr
Eyepoint Pharmaceuticals Q1 Earnings Call Highlights
Yahoo Top67 · bullishearnings